project id: TCGA-ACC; case submitter id: TCGA-OR-A5L8; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.05; rna integrity number: 9.4; age at index: 36; days to birth: -13472; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1975; age at diagnosis: 13472; ajcc clinical m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 885.0; icd 10 code: C74.0; last known disease status: not reported; morphology: 8370/3; primary diagnosis: Adrenal cortical carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cortex of adrenal gland; synchronous malignancy: No; tissue or organ of origin: Cortex of adrenal gland; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 558; initial weight: 70.0; sample id: ebfaaae3-9a83-498d-aa97-7cf19208d2da; sample submitter id: TCGA-OR-A5L8-01A; portion id: 04bebe22-3d53-4d7c-a57e-e794d1563b24; portion submitter id: TCGA-OR-A5L8-01A-11; slide id: 30f08b33-35ea-4ac9-94e5-a36b45a8f501; slide submitter id: TCGA-OR-A5L8-01A-01-TS1; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 5.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0; section location: TOP;